Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-01 Sale |
2025-04-03 4:21 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
10,000 | $15.12 | $151,236 | 121,944 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-03 4:21 pm |
Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer |
9,600 | $15.8 | $151,698 | 182,774 (Direct) |
View |
| 2025-03-24 Sale |
2025-03-26 4:41 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
3,671 | $17.55 | $64,413 | 1,156,383 (Indirect Direct) |
View |
| 2025-03-17 Sale |
2025-03-20 6:27 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,200 | $17.61 | $21,137 | 1,160,054 (Indirect Direct) |
View |
| 2025-03-13 Sale |
2025-03-17 4:51 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
61,403 | $14.99 | $920,510 | 536,678 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 7:44 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
3,773 | $13.1 | $49,408 | 308,089 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 7:43 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
25,015 | $13.07 | $327,019 | 1,557,254 (Indirect Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 7:43 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
10,000 | $13 | $130,048 | 131,944 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 7:43 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
3,263 | $13.03 | $42,520 | 298,429 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 8:01 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
8,338 | $12.7 | $105,893 | 178,692 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 8:01 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
19,301 | $12.7 | $245,123 | 1,035,269 (Indirect Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 8:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
10,000 | $12.71 | $127,100 | 141,944 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 8:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
12,116 | $12.7 | $153,873 | 114,862 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 8:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd See Remarks |
2,173 | $12.7 | $27,597 | 135,555 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-06 4:08 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
10,000 | $14.67 | $146,714 | 151,944 (Direct) |
View |
| 2024-12-31 Sale |
2024-12-31 6:13 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
1,691 | $14 | $23,674 | 126,978 (Direct) |
View |
| 2024-12-20 Sale |
2024-12-23 7:22 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
15,000 | $15.17 | $227,567 | 1,054,570 (Indirect Direct) |
View |
| 2024-11-30 Purchase |
2024-12-03 4:17 pm |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd See Remarks |
1,093 | $7.106 | $7,767 | 137,728 (Direct) |
View |
| 2024-05-31 Purchase |
2024-12-03 4:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
5,657 | $3.2778 | $18,543 | 187,030 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-03 4:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
10,000 | $12.51 | $125,133 | 161,944 (Direct) |
View |
| 2024-05-31 Purchase |
2024-12-03 4:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
6,038 | $3.5194 | $21,250 | 1,069,570 (Indirect Direct) |
View |
| 2024-11-22 Sale |
2024-11-26 4:21 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
16,023 | $10.14 | $162,515 | 347,169 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-19 7:52 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
1,775 | $9.6847 | $17,190 | 181,373 (Direct) |
View |
| 2024-11-14 Sale |
2024-11-18 7:04 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
69,226 | $10.29 | $712,621 | 597,815 (Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 6:45 pm |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
8,687 | $10.85 | $94,238 | 10,139 (Direct) |
View |
| 2024-11-04 Sale |
2024-11-05 4:46 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
5,015 | $8.6842 | $43,551 | 178,273 (Direct) |
View |
| 2024-11-04 Sale |
2024-11-05 4:46 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
13,871 | $8.6842 | $120,459 | 1,063,532 (Indirect Direct) |
View |
| 2024-11-01 Sale |
2024-11-05 4:46 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
10,000 | $8.6541 | $86,541 | 171,944 (Direct) |
View |
| 2024-11-04 Sale |
2024-11-05 4:45 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
15,441 | $8.6842 | $134,093 | 179,418 (Direct) |
View |
| 2024-10-01 Sale |
2024-10-03 4:55 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
10,000 | $9.2616 | $92,616 | 181,944 (Direct) |
View |
| 2024-10-02 Sale |
2024-10-03 4:55 pm |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd SVP Chief Commercial Officer |
3,725 | $10.01 | $37,295 | 136,635 (Direct) |
View |
| 2024-09-24 Sale |
2024-09-25 9:42 pm |
Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer |
11,626 | $9.4843 | $110,264 | 158,374 (Direct) |
View |
| 2024-09-03 Sale |
2024-09-05 5:56 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
10,000 | $10.77 | $107,695 | 191,944 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-21 4:39 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
1,728 | $8.286 | $14,318 | 194,859 (Direct) |
View |
| 2024-08-02 Sale |
2024-08-05 4:37 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
5,220 | $9.0161 | $47,064 | 183,288 (Direct) |
View |
| 2024-08-02 Sale |
2024-08-05 4:37 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
13,206 | $9.0191 | $119,106 | 196,587 (Direct) |
View |
| 2024-08-02 Sale |
2024-08-05 4:37 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
14,487 | $9.0183 | $130,648 | 1,077,403 (Indirect Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:37 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
10,000 | $9.8696 | $98,696 | 201,944 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-13 Exercise |
2025-03-17 4:51 pm |
N/A 2034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
17,250 | $0 | 536,678 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 7:44 pm |
N/A 2035-02-28 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
197,000 | $0 | 308,089 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 7:43 pm |
N/A 2035-02-28 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
547,000 | $0 | 1,557,254 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 7:43 pm |
N/A 2035-02-28 |
Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer |
123,000 | $0 | 281,374 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 7:43 pm |
N/A 2035-02-28 |
Arcutis Biotherapeutics Inc. | ARQT | Edwards Larry Todd See Remarks |
197,000 | $0 | 332,555 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 7:43 pm |
N/A 2035-02-28 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
123,000 | $0 | 298,429 (Direct) |
View |
| 2024-11-22 Exercise |
2024-11-26 4:21 pm |
N/A 2034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
16,023 | $0 | 347,169 (Direct) |
View |
| 2024-11-18 Option Award |
2024-11-19 7:52 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
4,875 | $0 | 181,373 (Direct) |
View |
| 2024-11-14 Exercise |
2024-11-18 7:04 pm |
N/A 2034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
18,477 | $0 | 597,815 (Direct) |
View |
| 2024-09-21 Option Award |
2024-09-25 9:42 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Topper David Joseph Chief Financial Officer |
60,000 | $0 | 158,374 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-05 4:37 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
6,614 | $0 | 201,944 (Direct) |
View |
| 2024-08-01 Exercise |
2024-08-05 4:37 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
6,614 | $1.6806 | 201,944 (Direct) |
View |